Delivery Order SPE2DB22D1106-SPE2DB24FEWE0

Award Date 6/10/24
Potential Completion Date 6/11/24
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Sevoflurane Inhalation Liquid 250ML to the Defense Logistics Agency (DLA), a defense agency. The $1,054.64 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has a completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,967.38 firm fixed-price delivery order is for the supply of 250 ml bottles of Sevoflurane inhalation liquid. The contract has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The federal contract award was issued to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,119.84, is a firm fixed price delivery order for the supply of 250 ml bottles of Sevoflurane inhalation liquid. This contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,723.82 fixed-price delivery order is for the supply of Sevoflurane inhalation liquid in 250 ml containers, with a performance period ending on April 23, 2024. Amerisourcebergen is a major pharmaceutical distribution company that has been awarded multiple federal contracts to provide a wide range of medical products and prescription drugs to various...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3103|SPE2DB24FQ0R0) for the supply of Sevoflurane Inhalation Liquid 250ML, with a firm fixed price ceiling value of $11,390.50. The award was issued by the Defense Logistics Agency (DLA), a defense agency, on August 27, 2024, with an ultimate completion date of August 28, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,950.24, is a Firm Fixed Price Delivery Order for the supply of Sevoflurane Inhalation Liquid 250ML. The contract has an ultimate completion date of February 21, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This contract awards Amerisourcebergen Drug Corp's Corporate Office Division a delivery order to supply 250 mL bottles of the anesthetic drug Sevoflurane to the Defense Logistics Agency (DLA). The $4,766.96 firm-fixed-price contract has a completion date of February 8, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of medical products and supplies to support the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the delivery of Sevoflurane Inhalation Liquid 250ML, a pharmaceutical product, with a total ceiling value of $4,556.20. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA, valued up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,525.98 firm fixed-price contract is for the delivery of 250 ml bottles of the anesthetic drug Sevoflurane Inhalation Liquid. The contract has a completion date of July 2, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
This federal contract award, valued at $2,733.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4561519438 - SEVOFLURANE INHALATION LIQUID 250ML, with an ultimate completion date of July 18, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEWE0
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4564860167 - Sevoflurane Inhalation Liquid 250ML. The contract, valued at $3,644.96, was awarded on June 10, 2024 by the Defense Logistics Agency (DLA) and has a completion date of June 11, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award did not utilize a set-aside designation.

Generated 9/9/24, 10:54 AM